Related Experiment Videos
Atosiban treatment for uterine hyperactivity during active labor: a pilot study
Samuel Lurie1, Oscar Sadan, Zahi Ben Aroya
1Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel. lurie@nashim.net
Journal of Perinatal Medicine
|April 17, 2004
Summary
Atosiban effectively treated uterine hyperactivity in most women during active labor. This tocolytic agent demonstrated rapid action and was well-tolerated, with no adverse neonatal outcomes observed.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
Background:
- Uterine hyperactivity can complicate active labor, potentially affecting maternal and fetal well-being.
- Intrauterine resuscitation measures are standard but may not always resolve excessive uterine activity.
Purpose of the Study:
- To preliminarily assess the efficacy of Atosiban in alleviating uterine hyperactivity during active labor.
Main Methods:
- A prospective observational study included 15 women with active labor and uterine hyperactivity.
- Atosiban was administered intravenously if initial resuscitation measures failed within 5 minutes.
Main Results:
- Atosiban alleviated uterine activity in 14 of 15 women, with rapid response in most.
- Fetal heart rate abnormalities improved in 13 of 14 cases.
- Atosiban was well-tolerated; no maternal or neonatal adverse events were reported, including Apgar scores and neonatal mortality.
Conclusions:
- Atosiban shows promise as an effective treatment for uterine hyperactivity in active labor.
- The drug appears safe for both mother and neonate in this context.